In focus
Latest feed
Hims & Hers (HIMS): Is That Short Squeeze a Dangerous Temptation or a Golden Opportunity?
A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar
Wall Street's Jitters: Inflation Fears and Shifting Fortunes for Key Stocks
Wegovy in Vials? Novo Nordisk's Strategic Shift to Boost Supply and Challenge Eli Lilly
Latest headlines
